Tools for More Personalized Myasthenia Gravis Care
Medscape InDiscussion: Myasthenia Gravis,
Drs Nicholas Silvestri and James "Chip" Howard discuss newer and novel myasthenia gravis tools to personalize treatment…
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled…
Overview of attention for article published in Lancet Neurology, October 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Mentioned by
- news
- 6 news outlets
- blogs
- 3 blogs
- policy
- 2 policy sources
- 28 X users
- patent
- 33 patents
- 3 Facebook pages
- wikipedia
- 1 Wikipedia page
- 1 Redditor
- f1000
- 1 research highlight platform
- guideline
- 6 clinical guideline sources
- podcasts
- 1 podcast
Readers on
- mendeley
- 589 Mendeley
- citeulike
- 1 CiteULike